Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT05103878
A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 24, 2020
Completion: Nov 13, 2020